Document is current
Any future updates will be listed below
-
Authors
Martínez-García, Javier
Molina, Manuela
Odriozola, Leticia
Molina, Angie
González-Aseguinolaza, Gloria
Weber, Nicholas D.
Smerdou, Cristian http://orcid.org/0000-0002-6861-6579
-
Funding
Funding for this research was provided by:
Vivet Therapeutics
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 26 April 2022
First Online: 31 May 2022
Declarations
:
: All animal experiments and procedures were approved by the Institutional Ethical Committee of the University of Navarra (protocol numbers: 082c-17 for breeding, 086–17 and 081–17 for animal studies).
: Not applicable.
: Drs. Weber and González-Aseguinolaza are employees of Vivet Therapeutics, a startup biopharmaceutical company developing gene therapy approaches for treatment of rare metabolic diseases. All other authors declare no competing interests.
